Mother-Infant Psychoanalysis Project of Stockholm (MIPPS)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Mother-infant relationship disturbances broadly comprise three areas; maternal distress, infant functional problems, and relationship difficulties. Given the high frequency of such disturbances and the relative paucity of randomized treatment studies, substantial systematic investigation is needed. This project is a randomized controlled study comparing mother-infant psychoanalytic treatment with treatment as usual in cases where mothers and/or health visitors demanded expert help.
| Condition | Intervention | Phase |
|---|---|---|
|
Mother-Infant Relational Disturbances |
Other: Treatment as Usual at Child Health Centre Other: Mother-Infant Psychoanalytic treatment (MIP) |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | A Randomized Controlled Trial of Mother-Infant Psychoanalytic Treatment and Treatment As Usual at Child Health Centres |
- the Parent-Infant Relationship Global Assessment Scale (PIR-GAS; ZERO-TO-THREE, 2005) [ Time Frame: Two interviews, six months apart ] [ Designated as safety issue: No ]
- the Edinburgh Postnatal Depression Scale (EPDS; Cox et al., 1987) [ Time Frame: Two interviews, six months apart ] [ Designated as safety issue: No ]
- the Ages and Stages Questionnaire: Social-Emotional, (ASQ:SE; Squires et al., 2002 [ Time Frame: Two interviews, six months apart ] [ Designated as safety issue: No ]
- the Swedish Parental Stress Questionnaire, (SPSQ; Östberg et al., 1997) [ Time Frame: Two interviews six months apart ] [ Designated as safety issue: No ]
- the Emotional Availability Scales, (EAS; Biringen, 1998) [ Time Frame: Two interviews, six months apart ] [ Designated as safety issue: No ]
| Enrollment: | 80 |
| Study Start Date: | October 2005 |
| Study Completion Date: | December 2008 |
| Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Mother-Infant Psychoanalytic treatment;MIP
MIP intervention
|
Other: Mother-Infant Psychoanalytic treatment (MIP)
MIP (Norman, 2001; 2004) is a psychoanalytic method adapted to the requirements of the infant as analysand in the presence of his mother. The analyst strives to recruit the baby for an emotional interchange, though this does not imply any belief whatsoever that the infant understands verbal communication. Rather, the analyst addresses the baby to help him liberate emotions consolidated in symptoms such as screaming, avoiding maternal eye contact, and breast refusal. The analyst takes great care in enrolling the participant mother. This is to enhance her understanding of the baby's predicament and the nature of their relation, as well as giving her all space needed to vent her own frustration, depression and anxiety.
|
|
Active Comparator: TAU
Treatment as usual
|
Other: Treatment as Usual at Child Health Centre
TAU involved scheduled health visitor calls at the local Child Health Centre (CHC), with paediatric checkups at 2 and 6 months of age. The health visitor is encouraged to promote attachment and to detect postnatal depressions. Mothers may be offered parental groups, infant massage or guidance promoting interaction, as well as appointments with a paediatrician or a child psychiatric psychologist. Within the TAU framework, additional treatment may be initiated by the health visitor or the mother. This will be registered at the end-point interview.
|
Detailed Description:
DESIGN
Eighty dyads with infants below 1½ years of age are interviewed and then randomly assigned to MIP or TAU. An end-point interview follows after ½ year, evaluating the intervention effects.
The MIP treatments are performed by IPA psychoanalysts at the Infant Reception Service of the Swedish Psychoanalytic Society. TAU implies contact with a Health Visitor at a Child Health Centre. Additional treatments within the TAU framework suggested at the initiative by the health visitor or the mother are registered at the end-point interview. Each TAU case will also be investigated via CHC records.
INSTRUMENTS
Mother-report questionnaires; the Ages and Stages Questionnaire:Social-Emotional (ASQ:SE; Squires et al., 2002), the Edinburgh Postnatal Depression Scale (EPDS; Cox et al., 1987)and the Swedish Parental Questionnaire (SPSQ; Östberg et al., 1997).
Independently rated video-taped mother-infant interactions: the Emotional Availability Scale (EAS; Biringen, 1998).
Relationship assessment: the Parent-Infant Relationship Global Assessment Scale (PIR-GAS; ZERO-TO-THREE, 2005).
Prognostic assessment: the Mother-Baby Interview (MOBI; Salomonsson, 2009). Interview-based assessments of psychoanalytic aptitude and quality of the process.
Ideal typing (Stuhr&Wachholz, 2001) of "maternal types" and "infant types."
Eligibility| Ages Eligible for Study: | up to 18 Months |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- The mother expressed significant concerns about one or more of the following domains: herself as a mother, her infant's well-being, or the mother-baby relationship (this was operationalized as a score < 80 ("perturbed relation") on the PIR-GAS or, alternatively, > 2.5 on the SPSQ).
- Infant of any gender, age below 18 months.
- Duration of worries exceeding two weeks.
- Domicile in Stockholm.
- Reasonable mastery of Swedish.
Exclusion Criteria:
- Maternal psychosis.
- Substance dependence according to DSM-IV, to an extent precluding collaboration.
No mothers met these criteria.
Contacts and Locations| Sweden | |
| Deptartment of Woman and Child Health, Child and Adolescent Psychiatry Unit, Karolinska Institute | |
| Stockholm, Sweden, 17176 | |
| Study Director: | Per-Anders Rydelius, Professor | Dept. of Woman and Child Health, Child and Adolescent Psychiatry Unit, Karolinska Institute |
More Information
Publications:
| Responsible Party: | Björn Salomonsson, Dept. of Woman and Child Health, Child and Adolescent Psychiatry Unit, Karolinska Institute |
| ClinicalTrials.gov Identifier: | NCT00923559 History of Changes |
| Other Study ID Numbers: | MIPPS-01 |
| Study First Received: | June 17, 2009 |
| Last Updated: | June 17, 2009 |
| Health Authority: | Sweden: Swedish Research Council |
ClinicalTrials.gov processed this record on May 16, 2013